" 314.170 
adulteration and misbranding of an approved drug. 
all drugs, including those the food and drug administration approves under section 505 of the act and this part, are subject to the adulteration and misbranding provisions in sections 501, 502, and 503 of the act. fda is authorized to regulate approved new drugs by regulations issued through informal rulemaking under sections 501, 502, and 503 of the act. 

